Searched for: in-biosketch:true
person:wangj28
Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer
Song, Heyu; Zeng, Jiping; Roychoudhury, Shrabasti; Biswas, Pranjal; Mohapatra, Bhopal; Ray, Sutapa; Dowlatshahi, Kayvon; Wang, Jing; Band, Vimla; Talmon, Geoffrey; Bhakat, Kishor K
Fluorouracil (5-FU) remains a first-line chemotherapeutic agent for colorectal cancer. However, a subset of colorectal cancer patients who have defective mismatch-repair (dMMR) pathway show resistance to 5-FU. Here, we demonstrate that the efficacy of 5-FU in dMMR colorectal cancer cells is largely dependent on the DNA base excision repair (BER) pathway. Downregulation of APE1, a key enzyme in the BER pathway, decreases IC50 of 5-FU in dMMR colorectal cancer cells by 10-fold. Furthermore, we discover that the facilitates chromatin transcription (FACT) complex facilitates 5-FU repair in DNA via promoting the recruitment and acetylation of APE1 (AcAPE1) to damage sites in chromatin. Downregulation of FACT affects 5-FU damage repair in DNA and sensitizes dMMR colorectal cancer cells to 5-FU. Targeting the FACT complex with curaxins, a class of small molecules, significantly improves the 5-FU efficacy in dMMR colorectal cancer in vitro (∼50-fold decrease in IC50) and in vivo xenograft models. We show that primary tumor tissues of colorectal cancer patients have higher FACT and AcAPE1 levels compared with adjacent nontumor tissues. Additionally, there is a strong clinical correlation of FACT and AcAPE1 levels with colorectal cancer patients' response to chemotherapy. Together, our study demonstrates that targeting FACT with curaxins is a promising strategy to overcome 5-FU resistance in dMMR colorectal cancer patients.
PMCID:6946866
PMID: 31575655
ISSN: 1538-8514
CID: 5865912
Interpretation of mitochondrial tRNA variants
Wong, Lee-Jun C; Chen, Ting; Wang, Jing; Tang, Sha; Schmitt, Eric S; Landsverk, Megan; Li, Fangyuan; Wang, Yue; Zhang, Shulin; Zhang, Victor Wei; Craigen, William J
PURPOSE:To develop criteria to interpret mitochondrial transfer RNA (mt-tRNA) variants based on unique characteristics of mitochondrial genetics and conserved structural/functional properties of tRNA. METHODS:We developed rules on a set of established pathogenic/benign variants by examining heteroplasmy correlations with phenotype, tissue distribution, family members, and among unrelated families from published literature. We validated these deduced rules using our new cases and applied them to classify novel variants. RESULTS:Evaluation of previously reported pathogenic variants found that 80.6% had sufficient evidence to support phenotypic correlation with heteroplasmy levels among and within families. The remaining variants were downgraded due to the lack of similar evidence. Application of the verified criteria resulted in rescoring 80.8% of reported variants of uncertain significance (VUS) to benign and likely benign. Among 97 novel variants, none met pathogenic criteria. A large proportion of novel variants (84.5%) remained as VUS, while only 10.3% were likely pathogenic. Detection of these novel variants in additional individuals would facilitate their classification. CONCLUSION:Proper interpretation of mt-tRNA variants is crucial for accurate clinical diagnosis and genetic counseling. Correlations with tissue distribution, heteroplasmy levels, predicted perturbations to tRNA structure, and phenotypes provide important evidence for determining the clinical significance of mt-tRNA variants.
PMID: 31965079
ISSN: 1530-0366
CID: 4967672
Ketamine normalizes high-gamma power in the anterior cingulate cortex in a rat chronic pain model
Friesner, Isabel D; Martinez, Erik; Zhou, Haocheng; Gould, Jonathan Douglas; Li, Anna; Chen, Zhe Sage; Zhang, Qiaosheng; Wang, Jing
Chronic pain alters cortical and subcortical plasticity, causing enhanced sensory and affective responses to peripheral nociceptive inputs. Previous studies have shown that ketamine had the potential to inhibit abnormally amplified affective responses of single neurons by suppressing hyperactivity in the anterior cingulate cortex (ACC). However, the mechanism of this enduring effect has yet to be understood at the network level. In this study, we recorded local field potentials from the ACC of freely moving rats. Animals were injected with complete Freund's adjuvant (CFA) to induce persistent inflammatory pain. Mechanical stimulations were administered to the hind paw before and after CFA administration. We found a significant increase in the high-gamma band (60-100Â Hz) power in response to evoked pain after CFA treatment. Ketamine, however, reduced the high-gamma band power in response to evoked pain in CFA-treated rats. In addition, ketamine had a sustained effect on the high-gamma band power lasting up to five days after a single dose administration. These results demonstrate that ketamine has the potential to alter maladaptive neural responses in the ACC induced by chronic pain.
PMCID:7513294
PMID: 32967695
ISSN: 1756-6606
CID: 4617632
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Davis, Karen D; Aghaeepour, Nima; Ahn, Andrew H; Angst, Martin S; Borsook, David; Brenton, Ashley; Burczynski, Michael E; Crean, Christopher; Edwards, Robert; Gaudilliere, Brice; Hergenroeder, Georgene W; Iadarola, Michael J; Iyengar, Smriti; Jiang, Yunyun; Kong, Jiang-Ti; Mackey, Sean; Saab, Carl Y; Sang, Christine N; Scholz, Joachim; Segerdahl, Marta; Tracey, Irene; Veasley, Christin; Wang, Jing; Wager, Tor D; Wasan, Ajay D; Pelleymounter, Mary Ann
Pain medication plays an important role in the treatment of acute and chronic pain conditions, but some drugs, opioids in particular, have been overprescribed or prescribed without adequate safeguards, leading to an alarming rise in medication-related overdose deaths. The NIH Helping to End Addiction Long-term (HEAL) Initiative is a trans-agency effort to provide scientific solutions to stem the opioid crisis. One component of the initiative is to support biomarker discovery and rigorous validation in collaboration with industry leaders to accelerate high-quality clinical research into neurotherapeutics and pain. The use of objective biomarkers and clinical trial end points throughout the drug discovery and development process is crucial to help define pathophysiological subsets of pain, evaluate target engagement of new drugs and predict the analgesic efficacy of new drugs. In 2018, the NIH-led Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain workshop convened scientific leaders from academia, industry, government and patient advocacy groups to discuss progress, challenges, gaps and ideas to facilitate the development of biomarkers and end points for pain. The outcomes of this workshop are outlined in this Consensus Statement.
PMID: 32541893
ISSN: 1759-4766
CID: 4496692
Mapping Cortical Integration of Sensory and Affective Pain Pathways
Singh, Amrita; Patel, Divya; Li, Anna; Hu, Lizbeth; Zhang, Qiaosheng; Liu, Yaling; Guo, Xinling; Robinson, Eric; Martinez, Erik; Doan, Lisa; Rudy, Bernardo; Chen, Zhe S; Wang, Jing
Pain is an integrated sensory and affective experience. Cortical mechanisms of sensory and affective integration, however, remain poorly defined. Here, we investigate the projection from the primary somatosensory cortex (S1), which encodes the sensory pain information, to the anterior cingulate cortex (ACC), a key area for processing pain affect, in freely behaving rats. By using a combination of optogenetics, in vivo electrophysiology, and machine learning analysis, we find that a subset of neurons in the ACC receives S1 inputs, and activation of the S1 axon terminals increases the response to noxious stimuli in ACC neurons. Chronic pain enhances this cortico-cortical connection, as manifested by an increased number of ACC neurons that respond to S1 inputs and the magnified contribution of these neurons to the nociceptive response in the ACC. Furthermore, modulation of this S1→ACC projection regulates aversive responses to pain. Our results thus define a cortical circuit that plays a potentially important role in integrating sensory and affective pain signals.
PMID: 32220320
ISSN: 1879-0445
CID: 4368562
Granger causality analysis of rat cortical functional connectivity in pain
Guo, Xinling; Zhang, Qiaosheng; Singh, Amrita; Wang, Jing; Chen, Zhe Sage
OBJECTIVE:The primary somatosensory cortex (S1) and the anterior cingulate cortex (ACC) are two most important brain regions encoding the sensory-discriminative and affective-emotional aspects of pain, respectively. However, the functional connectivity of these two areas during cortical pain processing remains unclear. Developing methods to dissect the functional connectivity and directed information flow between cortical pain circuits can reveal insight into neural mechanisms of pain perception. APPROACH/METHODS:We recorded multichannel local field potentials (LFPs) from the S1 and ACC from freely behaving rats under various conditions of pain stimulus (thermal vs. mechanical) and pain state (naive vs. chronic pain). We applied Granger causality (GC) analysis to the LFP recordings and inferred frequency-dependent GC statistics and directed information flow. MAIN RESULTS/RESULTS:We found increased information flow during noxious pain stimulus presentation in both S1-->ACC and ACC-->S1 directions, especially at theta and gamma frequency bands. Similar results were found between thermal and mechanical pain stimuli. The chronic pain state shares common observations, but with elevated GC statistics especially in the gamma band. Furthermore, time-varying GC analysis revealed negative correlation between direction-specific and frequency-dependent GC and animal's paw withdrawal latency. In addition, we used computer simulations to investigate the impact of model mismatch, noise, missing variables, and common input on the conditional GC estimate. We also compared the GC results with the transfer entropy (TE) estimates. SIGNIFICANCE/CONCLUSIONS:Our results reveal functional connectivity and directed information flow between the S1 and ACC during various pain conditions. The time-varying GC analysis support the cortico-cortical information loop consistent with the computational predictive coding paradigm.
PMID: 31945754
ISSN: 1741-2552
CID: 4261892
[EXPRESS] Sleep spindles as a diagnostic and therapeutic target for chronic pain
Caravan, Bassir; Hu, Lizabeth; Veyg, Daniel; Kulkarni, Prathamesh; Zhang, Qiaosheng; Chen, Zhe; Wang, Jing
Pain is known to disrupt sleep patterns, and disturbances in sleep can further worsen pain symptoms. Sleep spindles occur during slow wave sleep and have established effects on sensory and affective processing in mammals. A number of chronic neuropsychiatric conditions, meanwhile, are known to alter sleep spindle density. The effect of persistent pain on sleep spindle waves, however, remains unknown, and studies of sleep spindles are challenging due to long period of monitoring and data analysis. Utilizing automated sleep spindle detection algorithms built on deep learning, we can monitor the effect of pain states on sleep spindle activity. In this study, we show that in a chronic pain model in rodents, there is a significant decrease in sleep spindle activity compared to controls. Meanwhile, methods to restore sleep spindles are associated with decreased pain symptoms. These results suggest that sleep spindle density correlates with chronic pain and may be both a potential biomarker for chronic pain and a target for neuromodulaton therapy.
PMID: 31912761
ISSN: 1744-8069
CID: 4257342
Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death
Kulkarni, Prathamesh M; Robinson, Eric J; Sarin Pradhan, Jaya; Gartrell-Corrado, Robyn D; Rohr, Bethany R; Trager, Megan H; Geskin, Larisa J; Kluger, Harriet M; Wong, Pok Fai; Acs, Balazs; Rizk, Emanuelle M; Yang, Chen; Mondal, Manas; Moore, Michael R; Osman, Iman; Phelps, Robert; Horst, Basil A; Chen, Zhe S; Ferringer, Tammie; Rimm, David L; Wang, Jing; Saenger, Yvonne M
PURPOSE/OBJECTIVE:Biomarkers for disease specific survival (DSS) in early stage melanoma are needed to select patients for adjuvant immunotherapy and accelerate clinical trial design. We present a pathology-based computational method using a deep neural network architecture for DSS prediction. EXPERIMENTAL DESIGN/METHODS:The model was trained on 108 patients from four institutions and tested on 104 patients from Yale School of Medicine (YSM). A receiver operating characteristic (ROC) curve was generated based on vote aggregation of individual image sequences, an optimized cutoff was selected, and the computational model was tested on a third independent population of 51 patients from Geisinger Health Systems (GHS). RESULTS:Area under the curve (AUC) in the YSM patients was 0.905 (p<0.0001). AUC in the GHS patients was 0.880 (p<0.0001). Using the cutoff selected in the YSM cohort, the computational model predicted DSS in the GHS cohort based on Kaplan-Meier (KM) analysis (p<0.0001). CONCLUSIONS:The novel method presented is applicable to digital images, obviating the need for sample shipment and manipulation and representing a practical advance over current genetic and IHC-based methods.
PMID: 31636101
ISSN: 1078-0432
CID: 4169052
A Predictive Coding Model for Evoked and Spontaneous Pain Perception
Song, Yuru; Kemprecos, Helen; Wang, Jing; Chen, Zhe
Pain is a complex multidimensional experience, and pain perception is still incompletely understood. Here we combine animal behavior, electrophysiology, and computer modeling to dissect mechanisms of evoked and spontaneous pain. We record the local field potentials (LFPs) from the primary somatosensory cortex (S1) and anterior cingulate cortex (ACC) of freely behaving rats during pain episodes, and develop a predictive coding model to investigate the temporal coordination of oscillatory activity between the S1 and ACC. Our preliminary results from computational simulations support the experimental findings and provide new predictions.
PMID: 31946512
ISSN: 1557-170x
CID: 4271612
Neuromodulation for Pain Management
Wang, Jing; Chen, Zhe
Pain is a salient and complex sensory experience with important affective and cognitive dimensions. The current definition of pain relies on subjective reports in both humans and experimental animals. Such definition lacks basic mechanistic insights and can lead to a high degree of variability. Research on biomarkers for pain has previously focused on genetic analysis. However, recent advances in human neuroimaging and research in animal models have begun to show the promise of a circuit-based neural signature for pain. At the treatment level, pharmacological therapy for pain remains limited. Neuromodulation has emerged as a specific form of treatment without the systemic side effects of pharmacotherapies. In this review, we will discuss some of the current neuromodulatory modalities for pain, research on newer targets, as well as emerging possibility for an integrated brain-computer interface approach for pain management.
PMID: 31729677
ISSN: 0065-2598
CID: 4187052